(Q54562239)

1 June 2018

title

The impact of interleukin-6 promoter -597/-572/-174genotype on interleukin-6 production after lipopolysaccharide stimulation. (English)

1 reference

1 June 2018

0 references

0 references

M Müller-Steinhardt

1

1 reference

1 June 2018

B Ebel

series ordinal

2

1 reference

1 June 2018

C Härtel

series ordinal

3

1 reference

1 June 2018

publication date

1 February 2007

1 reference

1 June 2018

Clinical and Experimental Immunology

published in

1 reference

1 June 2018

volume

147

1 reference

1 June 2018

issue

2

1 reference

1 June 2018

page(s)

339-345

1 reference

1 June 2018

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Donor cytokine genotype influences the development of acute rejection after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

The -597 G-->A and -174 G-->C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Cooperative influence of the interleukin-6 promoter polymorphisms -597, -572 and -174 on long-term kidney allograft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis: the Carotid Atherosclerosis Progression Study (CAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

The optimal measure of allelic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Ex vivo induction of cytokine mRNA expression in human blood samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Immunosuppressive activity of the immunophilin-binding drug Sanglifehrin A in human whole blood: potent inhibition of interleukin-6 produced by lymphocytes and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1810465

Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1810465

The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians.

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1810465

Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1810465

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1810465

The biological effects of interleukin 6.

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1810465

On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion

7 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1810465

Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population

7 September 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.03273.X

Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis

21 January 2018

1 reference

12 December 2020

The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction

1 reference

12 December 2020

The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease

1 reference

12 December 2020

The interleukin-6 -174promoter polymorphism is associated with long-term kidney allograft survival

1 reference

12 December 2020

A human whole-blood assay for analysis of T-cell function by quantification of cytokine mRNA

1 reference

12 December 2020

Polymorphisms of genes involved in innate immunity: association with preterm delivery

1 reference

12 December 2020

A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women

1 reference

12 December 2020

10.1111/J.1365-2249.2006.03273.X

Identifiers

DOI

1 reference

1 June 2018

PMC publication ID

1810465

0 references

1 reference

1 June 2018